Jiangsu Hengrui reported CNY8.95B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Sh Fosun Pharma CNY 10.07B 50M Dec/2026
Sh Pharmaceutical CNY 75.49B 3.5B Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
Wuxi Apptec CNY 12.6B 4.04B Dec/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026